Independent equity research · India

Research that shows its working.

Per-company theses, version-stamped forward estimates, and valuation scenarios you can re-run with your own assumptions. One number, one source — it never disagrees across two pages.

No card to browse the free tier · Cancel anytime

Saraf Cements
BSE: SARCEM
Indicative
Current price₹642.10
Market cap₹24,890 cr
FY28 scenario · ×24 P/E
PAT ₹1,612 cr× 24 P/E
Implied m-cap₹38,688 cr
Expected return
+55.4%
Under coverageAnand LogisticsSaraf CementsVellore PharmaKomal Foods+ growing · fictional names, for demo

What's different

Three things you'll notice in the first ten minutes.

Estimates you can re-run

Every Stock and Valuation page has live calculators. Pick a P/E, apply it to the forward PAT, see the implied market cap and expected return. Your inputs, never saved.

One source of truth

PAT, revenue, thesis — all admin-entered and version-stamped. The FY27 PAT on the valuation table is the same number quoted in the thesis. It can't drift.

Only price is live

Current price and market cap are fetched live and clearly badged. Everything else is dated, so you always know how fresh a view is before you act.

Daily

Between the Lines

The daily read of what actually moved — not the headline print, but the one sentence in the concall that changes the model. Each note links straight to the company it's about.

Read the stream
Field

On the Ground

Channel checks, dealer surveys, hub visits. Where we leave the spreadsheet and go look. Primary evidence, tied back to the thesis it supports or challenges.

Read the stream

The thesis

“Most research tells you the conclusion. Sekhar Learning Corner hands you the model and lets you disagree with it.”

Pricing

Open to browse. Pay when you want the full model.

Free
₹0

Public sign-up. Browse coverage, read both streams, and run the basic valuation calculator.

  • · Coverage list + theses
  • · Both blog streams
  • · Live price & market cap
Create free account
Subscriber
₹1,499/mo

Everything in free, plus the full forward-estimate model and multi-year scenario tables.

  • · FY27–FY29 estimates
  • · Per-row P/E scenario builder
  • · Earnings & concall summaries + filings
Start 14-day trial

Stop reading conclusions. Start re-running them.

Free to browse. ₹1,499/mo for the full model.